effects of paeonol on anti-neuroinflammatory responses in microglial cells

Chingju Lin, Hsiao Yun Lin, Jia Hong Chen, Wen-Pei Tseng, Pei Ying Ko, Yu Shu Liu, Wei Lan Yeh, Dah Yuu Lu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Increasing studies suggest that inflammatory processes in the central nervous system mediated by microglial activation plays an important role in numerous neurodegenerative diseases. Development of planning for microglial suppression is considered a key strategy in the search for neuroprotection. Paeonol is a major phenolic component of Moutan Cortex, widely used as a nutrient supplement in Chinese medicine. In this study, we investigated the effects of paeonol on microglial cells stimulated by inflammagens. Paeonol significantly inhibited the release of nitric oxide (NO) and the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Treatment with paeonol also reduced reactive oxygen species (ROS) production and inhibited an ATP-induced increased cell migratory activity. Furthermore, the inhibitory effects of neuroinflammation by paeonol were found to be regulated by phosphorylated adenosine monophosphate-activated protein kinase-α (AMPK-α) and glycogen synthase kinase 3 α/β (GSK 3α/β). Treatment with AMPK or GSK3 inhibitors reverse the inhibitory effect of neuroinflammation by paeonol in microglial cells. Furthermore, paeonol treatment also showed significant improvement in the rotarod performance and microglial activation in the mouse model as well. The present study is the first to report a novel inhibitory role of paeonol on neuroinflammation, and presents a new candidate agent for the development of therapies for inflammation-related neurodegenerative diseases.

Original languageEnglish
Pages (from-to)8844-8860
Number of pages17
JournalInternational Journal of Molecular Sciences
Volume16
Issue number4
DOIs
Publication statusPublished - 2015 Apr 21

Fingerprint

Neurodegenerative diseases
Nitric oxide
Chemical activation
nitric oxide
Adenosinetriphosphate
Neurology
cells
activation
glycogens
Nutrients
Medicine
adenosine monophosphate
central nervous system
adenosine triphosphate
cortexes
nutrients
supplements
Proteins
medicine
Planning

All Science Journal Classification (ASJC) codes

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

Lin, Chingju ; Lin, Hsiao Yun ; Chen, Jia Hong ; Tseng, Wen-Pei ; Ko, Pei Ying ; Liu, Yu Shu ; Yeh, Wei Lan ; Lu, Dah Yuu. / effects of paeonol on anti-neuroinflammatory responses in microglial cells. In: International Journal of Molecular Sciences. 2015 ; Vol. 16, No. 4. pp. 8844-8860.
@article{68eb2ceda00e4d19b4faadebab3c276b,
title = "effects of paeonol on anti-neuroinflammatory responses in microglial cells",
abstract = "Increasing studies suggest that inflammatory processes in the central nervous system mediated by microglial activation plays an important role in numerous neurodegenerative diseases. Development of planning for microglial suppression is considered a key strategy in the search for neuroprotection. Paeonol is a major phenolic component of Moutan Cortex, widely used as a nutrient supplement in Chinese medicine. In this study, we investigated the effects of paeonol on microglial cells stimulated by inflammagens. Paeonol significantly inhibited the release of nitric oxide (NO) and the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Treatment with paeonol also reduced reactive oxygen species (ROS) production and inhibited an ATP-induced increased cell migratory activity. Furthermore, the inhibitory effects of neuroinflammation by paeonol were found to be regulated by phosphorylated adenosine monophosphate-activated protein kinase-α (AMPK-α) and glycogen synthase kinase 3 α/β (GSK 3α/β). Treatment with AMPK or GSK3 inhibitors reverse the inhibitory effect of neuroinflammation by paeonol in microglial cells. Furthermore, paeonol treatment also showed significant improvement in the rotarod performance and microglial activation in the mouse model as well. The present study is the first to report a novel inhibitory role of paeonol on neuroinflammation, and presents a new candidate agent for the development of therapies for inflammation-related neurodegenerative diseases.",
author = "Chingju Lin and Lin, {Hsiao Yun} and Chen, {Jia Hong} and Wen-Pei Tseng and Ko, {Pei Ying} and Liu, {Yu Shu} and Yeh, {Wei Lan} and Lu, {Dah Yuu}",
year = "2015",
month = "4",
day = "21",
doi = "10.3390/ijms16048844",
language = "English",
volume = "16",
pages = "8844--8860",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "4",

}

effects of paeonol on anti-neuroinflammatory responses in microglial cells. / Lin, Chingju; Lin, Hsiao Yun; Chen, Jia Hong; Tseng, Wen-Pei; Ko, Pei Ying; Liu, Yu Shu; Yeh, Wei Lan; Lu, Dah Yuu.

In: International Journal of Molecular Sciences, Vol. 16, No. 4, 21.04.2015, p. 8844-8860.

Research output: Contribution to journalArticle

TY - JOUR

T1 - effects of paeonol on anti-neuroinflammatory responses in microglial cells

AU - Lin, Chingju

AU - Lin, Hsiao Yun

AU - Chen, Jia Hong

AU - Tseng, Wen-Pei

AU - Ko, Pei Ying

AU - Liu, Yu Shu

AU - Yeh, Wei Lan

AU - Lu, Dah Yuu

PY - 2015/4/21

Y1 - 2015/4/21

N2 - Increasing studies suggest that inflammatory processes in the central nervous system mediated by microglial activation plays an important role in numerous neurodegenerative diseases. Development of planning for microglial suppression is considered a key strategy in the search for neuroprotection. Paeonol is a major phenolic component of Moutan Cortex, widely used as a nutrient supplement in Chinese medicine. In this study, we investigated the effects of paeonol on microglial cells stimulated by inflammagens. Paeonol significantly inhibited the release of nitric oxide (NO) and the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Treatment with paeonol also reduced reactive oxygen species (ROS) production and inhibited an ATP-induced increased cell migratory activity. Furthermore, the inhibitory effects of neuroinflammation by paeonol were found to be regulated by phosphorylated adenosine monophosphate-activated protein kinase-α (AMPK-α) and glycogen synthase kinase 3 α/β (GSK 3α/β). Treatment with AMPK or GSK3 inhibitors reverse the inhibitory effect of neuroinflammation by paeonol in microglial cells. Furthermore, paeonol treatment also showed significant improvement in the rotarod performance and microglial activation in the mouse model as well. The present study is the first to report a novel inhibitory role of paeonol on neuroinflammation, and presents a new candidate agent for the development of therapies for inflammation-related neurodegenerative diseases.

AB - Increasing studies suggest that inflammatory processes in the central nervous system mediated by microglial activation plays an important role in numerous neurodegenerative diseases. Development of planning for microglial suppression is considered a key strategy in the search for neuroprotection. Paeonol is a major phenolic component of Moutan Cortex, widely used as a nutrient supplement in Chinese medicine. In this study, we investigated the effects of paeonol on microglial cells stimulated by inflammagens. Paeonol significantly inhibited the release of nitric oxide (NO) and the expressions of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2). Treatment with paeonol also reduced reactive oxygen species (ROS) production and inhibited an ATP-induced increased cell migratory activity. Furthermore, the inhibitory effects of neuroinflammation by paeonol were found to be regulated by phosphorylated adenosine monophosphate-activated protein kinase-α (AMPK-α) and glycogen synthase kinase 3 α/β (GSK 3α/β). Treatment with AMPK or GSK3 inhibitors reverse the inhibitory effect of neuroinflammation by paeonol in microglial cells. Furthermore, paeonol treatment also showed significant improvement in the rotarod performance and microglial activation in the mouse model as well. The present study is the first to report a novel inhibitory role of paeonol on neuroinflammation, and presents a new candidate agent for the development of therapies for inflammation-related neurodegenerative diseases.

UR - http://www.scopus.com/inward/record.url?scp=84928151879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928151879&partnerID=8YFLogxK

U2 - 10.3390/ijms16048844

DO - 10.3390/ijms16048844

M3 - Article

C2 - 25906473

AN - SCOPUS:84928151879

VL - 16

SP - 8844

EP - 8860

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 4

ER -